Results 211 to 220 of about 163,596 (354)

A case of eosinophilic otitis media successfully treated by tympanoplasty with use of dupilumab

, 2021
Saori Kikuchi, Saeko Yoshida, Tomonori Sugiyama, Yukiko Iino   +3 more
openalex   +1 more source

Otitis Externa [PDF]

BMJ, 1937
openaire   +2 more sources

Do We Have Any Environmental or Perinatal Factor Which May Predispose for Paediatric Airways Diseases? An Italian Population Prospective Study

Clinical Otolaryngology, Volume 51, Issue 1, Page 73-84, January 2026.
ABSTRACT Background Paediatric airway diseases such as asthma, allergies, rhinitis, upper respiratory tract infections and acute otitis media are major health challenges for children globally. The prevalence of these conditions has been increasing, impacting children's quality of life, educational attainment and imposing a substantial economic burden ...
Cecilia Rosso, Federica Turati, Alberto Maria Saibene, Elvira Verduci, Giuseppe Banderali, Monica Ferraroni, Giovanni Felisati, Carlotta Pipolo   +7 more
wiley   +1 more source

<i>Kerstersia gyiorum-</i>Caused Chronic Osteomyelitis in a Male Patient with Cerebral Infarction: A Case Report and Literature Review. [PDF]

Infect Drug Resist
Zhang T, Zhu B, Huang C.
europepmc   +1 more source

The potential use of phage therapy in the treatment of exacerbated chronic suppurative otitis media

A V Kryukov, A. V. Gurov, E. G. Lapenko
openalex   +2 more sources

An observational study of Microbial profile of patients with Chronic Suppurative Otitis Media (CSOM): A hospital based study

, 2017
Md. Sarfaraz
openalex   +1 more source

Primary Antibody Deficiency in Patients With Chronic Rhinosinusitis: A Call for Immunologic Evaluation Prior to Biologic Therapy

Clinical Otolaryngology, Volume 51, Issue 1, Page 144-152, January 2026.
ABSTRACT Objective Chronic rhinosinusitis (CRS) is prevalent and causes a great negative impact on quality of life. Primary antibody deficiency (PAD) is highly prevalent with CRS compared to the background population. There are efficient treatment options to consider when CRS is a symptom of PAD. The condition seems to be underdiagnosed.
Anita García Petersen, Kasra Zainali‐Gill, Carsten Schade Larsen, Christian Nielsen, Therese Ovesen   +4 more
wiley   +1 more source

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

Otitis media due to Vibrio cholerae non-O1/O139: A case report and short review

Diego Fernando Regalado Bermeo, Leticia Armendáriz López, Marta Adelantado Lacasa   +2 more
openalex   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source